BIOFRONTERA INC (BFRI)
US09077D2099 - Common Stock
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
If you want the chance at possible absurd returns, then consider gambling on these stocks to turn $1,000 into $1 million.
BFRI Stock Earnings: Biofrontera Beats EPS, Misses Revenue for Q4 2023
BFRI stock results show that Biofrontera beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
BFRI Stock Earnings: Biofrontera Beats EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biofrontera (NASDAQ:BFRI) just reported results for the fourth quarter of 2023....
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Wednesday!
Why Is GRI Bio (GRI) Stock Down 21% Today?
GRI Bio stock is falling on Friday after the company announced a public offering for 5 million shares of its stock and warrants.
Why Is TruGolf (TRUG) Stock Up 35% Today?
TruGolf stock is rallying on Friday after shares of TRUG fell hard on Thursday with their first day of trading after a SPAC merger.
Why Is Biofrontera (BFRI) Stock Down Today?
Biofrontera stock is experiencing extreme volatility on Friday morning with BFRI shares starting off up but falling shortly after that rally.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers worth keeping tabs on Friday!
Biofrontera files to sell common stock, warrants (NASDAQ:BFRI)
Biofrontera filed a prospectus for the sale of its shares and warrants, but did not disclose any specific amount.
Biofrontera sees 19% growth in prelim FY 2023 revenue (NASDAQ:BFRI)
Biofrontera (BFRI) reports record-high revenues of $33.8M to $34.3M for 2023, representing a 19% growth compared to 2022.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another busy day of trading as we go over the biggest pre-market stock movers worth watching on Tuesday morning!
Biofrontera files to sell shares, warrants (NASDAQ:BFRI)
Biopharmaceutical company Biofrontera (BFRI) files prospectus to sell shares and warrants, offering securities at a fixed combined purchase price.